Nanoparticles for topical application in the treatment of skin dysfunctions—an overview of dermo-cosmetic and dermatological products

M Raszewska-Famielec, J Flieger - International Journal of Molecular …, 2022 - mdpi.com
Nanomaterials (NM) arouse interest in various fields of science and industry due to their
composition-tunable properties and the ease of modification. They appear currently as …

The interleukin-8 pathway in cancer

DJJ Waugh, C Wilson - Clinical cancer research, 2008 - AACR
Abstract Interleukin-8 (IL-8) is a proinflammatory CXC chemokine associated with the
promotion of neutrophil chemotaxis and degranulation. This chemokine activates multiple …

[HTML][HTML] Applications of nanotechnology in dermatology

LA DeLouise - Journal of Investigative Dermatology, 2012 - Elsevier
What are nanoparticles and why are they important in dermatology? These questions are
addressed by highlighting recent developments in the nanotechnology field that have …

Targeted drug delivery to melanoma

Q Liu, M Das, Y Liu, L Huang - Advanced Drug Delivery Reviews, 2018 - Elsevier
Melanoma derived from melanocytes is the most aggressive genre of skin cancer. Although
the considerable advancement in the study of human cancer biology and drug discovery …

ABCB5 maintains melanoma-initiating cells through a proinflammatory cytokine signaling circuit

BJ Wilson, KR Saab, J Ma, T Schatton, P Pütz, Q Zhan… - Cancer research, 2014 - AACR
The drug efflux transporter ABCB5 identifies cancer stem–like cells (CSC) in diverse human
malignancies, where its expression is associated with clinical disease progression and …

CXCR4 signaling regulates metastasis of chemoresistant melanoma cells by a lymphatic metastatic niche

M Kim, YJ Koh, KE Kim, BI Koh, DH Nam, K Alitalo… - Cancer research, 2010 - AACR
Highly metastatic and chemotherapy-resistant properties of malignant melanomas stand as
challenging barriers to successful treatment; yet, the mechanisms responsible for their …

Current systemic therapy for metastatic melanoma

SS Agarwala - Expert review of anticancer therapy, 2009 - Taylor & Francis
Metastatic melanoma remains a lethal disease with a long-term remission rate of less than
10%. Despite many years of research, there has not been a new drug approved in this …

Cytokine profile of conditioned medium from human tumor cell lines after acute and fractionated doses of gamma radiation and its effect on survival of bystander tumor …

S Desai, A Kumar, S Laskar, BN Pandey - Cytokine, 2013 - Elsevier
Cytokines are known to play pivotal roles in cancer initiation, progression and pathogenesis.
Accumulating evidences suggest differences in basal and stress-induced cytokine profiles of …

[HTML][HTML] Adjuvant low-dose interferon α2a with or without dacarbazine compared with surgery alone: a prospective-randomized phase III DeCOG trial in melanoma …

C Garbe, P Radny, R Linse, R Dummer, R Gutzmer… - Annals of …, 2008 - Elsevier
Background More than half of patients with melanoma that has spread to regional lymph
nodes develop recurrent disease within the first 3 years after surgery. The aim of the study …

[HTML][HTML] How to MEK the best of uveal melanoma: A systematic review on the efficacy and safety of MEK inhibitors in metastatic or unresectable uveal melanoma

T Steeb, A Wessely, T Ruzicka, MV Heppt… - European Journal of …, 2018 - Elsevier
Background BRAF and MEK inhibitors have demonstrated significant survival benefits for
patients with cutaneous melanoma. However, their use for uveal melanoma (UM) is less …